GenTel BioSciences, Inc. Launches APiX(TM) Disease Profiling Kit to Enable Condition-Focused Proteomics Research and Discovery

7/28/2010 8:14:10 AM

MADISON, Wis.--(BUSINESS WIRE)--Gentel Biosciences, a leader in proteomics discovery tools, announces the availability of the APiX™ Disease Profiling Kit, a robust, cost-effective single-capture antibody array and detection kit suitable for profiling hundreds of disease-related proteins across multiple disease states.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• GenTel BioSciences, Inc.

• Biotech/Pharma - Supplier News